Pathogenic Alzheimer’s disease cascade is activated by faulty norepinephrine signaling
University of Alabama at BirminghamPreclinical research has revealed a key missing piece of the Alzheimer’s disease puzzle. That allowed proof-of-concept experiments — using an existing drug — that dramatically reduced Alzheimer’s pathology and symptoms in mouse models, potentially offering an immediate treatment for this disease.